NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE

Neelima Vidula, MD

Articles by Neelima Vidula, MD

Regaining Control of the Cell Cycle With CDK 4/6 Inhibitors: A Promising Targeted Therapy for Breast Cancer

ByNeelima Vidula, MD

September 22nd 2014

Therapies targeted to tumor biology hold the promise of improved outcomes for patients with breast cancer.

Latest Updated Articles

Regaining Control of the Cell Cycle With CDK 4/6 Inhibitors: A Promising Targeted Therapy for Breast Cancer
September 22nd 2014

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma

ASCO 2026 GU Cancer Highlights: Beyond the LBAs

Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC

FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer

Targeting the IL-2 Pathway to Overcome Immunotherapy Resistance in Melanoma